Contact this trialFirst, we need to learn more about you.
Anti-tumor antibiotic
DZD9008 vs Chemotherapy for Lung Cancer
Recruiting2 awardsPhase 3
Margate, Florida
"This trial is comparing a new drug called DZD9008 to standard chemotherapy in patients with a type of lung cancer called NSCLC that has a specific genetic mutation. The study aims to see
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service